Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandrine Ferrand

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Assay and Drug Development Technologies|July 3, 2008
Scintillation proximity assays in high-throughput screeningJ Fraser Glickman, Andres Schmid, Sandrine Ferrand
Assay and Drug Development Technologies|September 27, 2005
Statistical evaluation of a self-deconvoluting matrix strategy for high-throughput screening of the CXCR3 receptorSandrine Ferrand, Andres Schmid, Caroline Engeloch, et al.
Journal of Biomolecular Screening|May 20, 2011
Screening for mevalonate biosynthetic pathway inhibitors using sensitized bacterial strainsSandrine Ferrand, Jianshi Tao, Xiaoyu Shen, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 4, 2009
Hypothesis-driven screeningUlrich Schopfer, Caroline Engeloch, Frank Höhn, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2008
Inhibition of PHF-like tau hyperphosphorylation in SH-SY5Y cells and rat brain slices by K252aGabriele Hübinger, Silvia Geis, Sylvie LeCorre, et al.
Plos One|September 21, 2016
High Throughput Random Mutagenesis and Single Molecule Real Time Sequencing of the Muscle Nicotinic Acetylcholine ReceptorPaul J Groot-Kormelink, Sandrine Ferrand, Nicholas Kelley, et al.
Plos One|August 31, 2013
Breakpoint features of genomic rearrangements in neuroblastoma with unbalanced translocations and chromothripsisValentina Boeva, Stéphanie Jouannet, Romain Daveau, et al.
Cancer Research|November 10, 2012
Characterization of rearrangements involving the ALK gene reveals a novel truncated form associated with tumor aggressiveness in neuroblastomaAlex Cazes, Caroline Louis-Brennetot, Pierre Mazot, et al.
Plos One|July 12, 2014
Clinical characteristics and outcome of patients with neuroblastoma presenting genomic amplification of loci other than MYCNAnne Guimier, Sandrine Ferrand, Gaëlle Pierron, et al.
European Journal of Human Genetics : EJHG|November 11, 2011
ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndromeFranck Bourdeaut, Sandrine Ferrand, Laurence Brugières, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Assay and Drug Development Technologies|July 3, 2008
Scintillation proximity assays in high-throughput screeningJ Fraser Glickman, Andres Schmid, Sandrine Ferrand
Assay and Drug Development Technologies|September 27, 2005
Statistical evaluation of a self-deconvoluting matrix strategy for high-throughput screening of the CXCR3 receptorSandrine Ferrand, Andres Schmid, Caroline Engeloch, et al.
Journal of Biomolecular Screening|May 20, 2011
Screening for mevalonate biosynthetic pathway inhibitors using sensitized bacterial strainsSandrine Ferrand, Jianshi Tao, Xiaoyu Shen, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 4, 2009
Hypothesis-driven screeningUlrich Schopfer, Caroline Engeloch, Frank Höhn, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2008
Inhibition of PHF-like tau hyperphosphorylation in SH-SY5Y cells and rat brain slices by K252aGabriele Hübinger, Silvia Geis, Sylvie LeCorre, et al.
Plos One|September 21, 2016
High Throughput Random Mutagenesis and Single Molecule Real Time Sequencing of the Muscle Nicotinic Acetylcholine ReceptorPaul J Groot-Kormelink, Sandrine Ferrand, Nicholas Kelley, et al.
Plos One|August 31, 2013
Breakpoint features of genomic rearrangements in neuroblastoma with unbalanced translocations and chromothripsisValentina Boeva, Stéphanie Jouannet, Romain Daveau, et al.
Cancer Research|November 10, 2012
Characterization of rearrangements involving the ALK gene reveals a novel truncated form associated with tumor aggressiveness in neuroblastomaAlex Cazes, Caroline Louis-Brennetot, Pierre Mazot, et al.
Plos One|July 12, 2014
Clinical characteristics and outcome of patients with neuroblastoma presenting genomic amplification of loci other than MYCNAnne Guimier, Sandrine Ferrand, Gaëlle Pierron, et al.
European Journal of Human Genetics : EJHG|November 11, 2011
ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndromeFranck Bourdeaut, Sandrine Ferrand, Laurence Brugières, et al.
Pageof 2